What Home DNA Tests Really Tell Us
23andMe recently gained FDA approval, but will it actually help keep people healthier?
Fred's Could Help Rite Aid/Walgreens Deal Go Through
The chain has said it remains committed to buying Rite Aid stores.
An Opioid Story Earns a Pulitzer
A reporter earned the biggest journalism prize covering the opioid crisis.
Pharmacists Are Central to Supervalu Diabetes Campaign
Supervalu’s diabetes campaign offers risk assessments, screening, and food education.
Study: New Diabetes Drug Class Reduces Heart Deaths
New class of glucose-lowering agents lowers hospitalization and death rates even in Type 2 patients without heart disease.
The Trump Administration Gets Tough on Opioids
Trump and Gottlieb are both taking steps to end the opioid epidemic. But is it enough?
Small Doses: Pharmacy News Featuring Opioids, Ketamine, and More
Small Doses is news for pharmacists in a way that works for you.
Walgreens and Prime Therapeutics Create Specialty Pharma Mail Firm
What the new company will mean for specialty pharmacy.
MS Group Praises New Drug Despite High Price Tag
Why a drug that costs $65,000 a year is making patient groups happy.
GSK Issues Voluntary Recall
Nearly 600,000 inhalers are being recalled.
EpiPen and EpiPen Jr. Recalled: Recall Expanded from Europe and Asia
Two previous reports of device failures lead EpiPen maker to expand recall to the United States.
The Full Extent of Antibiotic Use in the United States? No One Knows.
What we know-and what we don't-about antibiotics in America.
The Health Economics of Medical Pot and the Pharmacist’s Role
Even medical marijuana has health-care costs and outcomes.
WHO Launches Program to Reduce Medication Errors
How a program hopes to cut errors in half.
As More Canadian Provinces Mandate Error Reporting, U.S. Experts Call for Similar Laws
Ontario joins Nova Scotia in making medication dispensing error reporting mandatory, but no states have enacted similar laws.
What to do About Rising Health-Care Costs?
Taking a clear-eyed look at the cost of health care can reduce waste.
What’s in the Specialty Pharmacy Pipeline?
Biosimilars, cancer drugs, and orphan drugs are heading towards FDA approval in 2017.
New York City Program Aims to Slash Opioid Deaths
What New York City is doing to curb the opioid epidemic.
Roundup of the APhA 2017 Annual Meeting and Exposition
This year's meeting highlighted the opioid epidemic and ways pharmacists can improve patient care.
Small Doses: News for Pharmacists
This week, take a look at studies and news on supplements, depression, opioids, and more. Small doses is the news you need in a way that works for you.
Pharmacists to Descend on Washington
DIR fees and health-care reform will lead pharmacists’ legislative concerns.
9 Newly Approved Novel Drugs
It's still early in 2017, but the FDA has been approving drugs left and right. Here's what you need to know.
EpiPens Recalled Overseas Due to Reported Failures
Two device failures lead Mylan to recall more than 80,000 EpiPens overseas.
Early Studies of Needle-Free Vaccine Delivery System Show Promise
A pill-like device that pumps vaccine into the mouth may make syringes obsolete.
Study Finds Nearly Half a Million Deaths Prevented in the United States by Vaccines
Over 55 years, 450,000 people stayed alive and 200 million people stayed well in the United States because of vaccines.
ASHP Releases Preceptor Guide
There is finally a one-stop resource available preceptor development.
Pharmacists Credited for Decline in Hospital-Acquired Conditions
In the battle against ADEs, pharmacists are leading the way.
Drug Topics Welcomes New Editorial Board Members
New board members are helping to keep our publication great.
Can Your Pharmacy Cure All This?
On a recent trip to Laos, one of our editors discovered a mobile pharmacy peddling herbal medications for everything from chickenpox to lung cancer.
FDA Issues Warning for Eluxadoline
Anti-IBS drug Viberzi (eluxadoline) increases risk of severe pancreatitis.
